ReviewFrontiers in immunology2026

Preferential phosphodiesterase inhibition as a novel strategy to modulate key pathways in systemic sclerosis.

Jörg H W Distler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.